Innoterra Bioscience Private Limited - Company Profile

It is a information technology private limited company based in Mumbai, Maharashtra, India, established in 2010.
2010 Mumbai, Maharashtra, India Active
Last Updated:
Access Report
About Innoterra Bioscience Private Limited

Innoterra Bioscience Private Limited, a active private limited company, was established on 02 July 2010 in Mumbai, Maharashtra, India. Engaging in it consulting & support services within the information and communication sector, it holds CIN: U20211MH2010PTC205170. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹16.50 Cr and a paid-up capital of ₹15.88 Cr.

Formerly known as Innoterra Tech India Private Limited, Lateral Praxis (India) Private Limited. It upholds a compliant status. Its leadership includes Kasinathan Krishna Kumar Avinash (Director), Ankur Tripathi (Additional Director), Shubhda Nautiyal (Additional Director). Past directors included Suniti Gupta, Pablo Erat, Anup Subhash Karwa. It holds no open charges and ₹1.50 M settled loans. Its latest AGM occurred on 22 September 2025, with the balance sheet filed on 31 March 2025. It is based at Unit 801-802, 8Th Floor, Tower 1, One International Center,, Senapati Bapat Marg, Prabhadevi,, Mumbai, Maharashtra, 400013.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U20211MH2010PTC205170

  • Registration Number

    205170

  • Incorporation Date

    02 July 2010

  • Authorized Capital

    ₹16.50 Cr

  • Paid-Up Capital

    ₹15.88 Cr

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 16.50 Cr
  • Paid Up Capital ₹ 15.88 Cr
  • Company Age 15 Year, 7 Months
  • Last Filing with ROC 31 Mar 2025
  • Satisfied Charges ₹ 1.50 M
  • Revenue Growth **** -40.88%
  • Profit Growth **** 69.43%
  • Ebitda **** 69.83%
  • Net Worth 81.17%
  • Total Assets **** 24.82%
Company report

Innoterra Bioscience Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Innoterra Bioscience Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Innoterra Bioscience Private Limited?
Current Directors
Name Designation Appointment Date Status
Kasinathan Krishna Kumar Avinash Director 12 Jul 2024 Current
Ankur Tripathi Additional Director 30 Jul 2025 Current
Shubhda Nautiyal Additional Director 01 Aug 2025 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 16 May 2020 Past
Pramod Abcsdd Additional Director 08 Aug 2022 Past
Pramod Abcsdd Additional Director 10 Jul 2023 Past
Pramod Abcsdd Director 07 Jul 2010 Past
Pramod Abcsdd Additional Director 29 Dec 2020 Past
Pramod Abcsdd Director 18 Mar 2024 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Innoterra Bioscience.

Innoterra Bioscience Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 40.88% decrease. The company also saw a substantial improvement in profitability, with a 69.43% increase in profit. The company's net worth Soared by an impressive increase of 81.17%.

Innoterra Bioscience revenue growth over time
Innoterra Bioscience profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -40.88%
*******
*******
*******
*******
Revenue from Operations
*******
 -42.92%
*******
*******
*******
*******
Total Assets
*******
 24.82%
*******
*******
*******
*******
Profit or Loss
*******
 69.43%
*******
*******
*******
*******
Net Worth
*******
 81.17%
*******
*******
*******
*******
EBITDA
*******
 69.83%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Innoterra Bioscience?

In 2023, Innoterra Bioscience had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹0

Satisfied Charges

₹1,500,000.00

Charges Breakdown by Lending Institutions
  • Bank Of India : 0.15 Cr
Latest Charge Details
Date Lender Amount Status
28 Dec 2011 Bank Of India ₹1.50 M Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Innoterra Bioscience?

Unlock and access historical data on people associated with Innoterra Bioscience, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Innoterra Bioscience, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Innoterra Bioscience's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Innoterra Bioscience
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Innoterra Bioscience Private Limited last Annual general meeting of members was held on 22 Sep 2025 as per latest MCA records. was documented.

  • Director Appointment

    The activity Shubhda Nautiyal was appointed as a Additional Director was appointed as a Additional Director on 01 Aug 2025 & has been associated with this company since 6 months 14 days . was completed.

  • Director Appointment

    Progress on Ankur Tripathi was appointed as a Additional Director was appointed as a Additional Director on 30 Jul 2025 & has been associated with this company since 6 months 16 days . was documented.

  • Balance Sheet

    Progress on Innoterra Bioscience Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was documented.

  • Director Appointment

    Dhanashree Shrinath Bhairi was appointed as a Company Secretary was appointed as a Company Secretary on 10 Mar 2025 & has been associated with this company since 11 months 5 days . was recorded as a recent event.

  • Director Appointment

    The activity Kasinathan Krishna Kumar Avinash was appointed as a Director was appointed as a Director on 12 Jul 2024 & has been associated with this company since 1 year 7 months . was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Innoterra Bioscience Private Limited?

The CIN of Innoterra Bioscience Private Limited is U20211MH2010PTC205170.

Where is Innoterra Bioscience Private Limited headquartered?

Innoterra Bioscience Private Limited is headquartered at Unit 801-802, 8Th Floor, Tower 1, One International Center,, Senapati Bapat Marg, Prabhadevi,, Mumbai, Maharashtra, 400013.

When was Innoterra Bioscience Private Limited incorporated?

Innoterra Bioscience Private Limited was incorporated on 02 July 2010.

Who are the current directors of Innoterra Bioscience Private Limited?

The current directors of Innoterra Bioscience Private Limited are

What is the primary industry of Innoterra Bioscience Private Limited?

The primary industry of Innoterra Bioscience Private Limited is Information And Communication.

Is Innoterra Bioscience Private Limited a listed company?

Innoterra Bioscience Private Limited is unlisted.

What is the capital structure of Innoterra Bioscience Private Limited?

The authorized capital of Innoterra Bioscience Private Limited is ₹16.50 Cr, and the paid-up capital is ₹15.88 Cr.

What is the compliance status of Innoterra Bioscience Private Limited?

The compliance status of Innoterra Bioscience Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available